Trial intelligence / Profile preview

Rivastigmine for cognitive impairment in schizophrenia

IRCT201110083010N3Phase 2Completed

Sponsor

Kermanshah University of Medical Sciences

Start

Mar 2011

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1